IL-1β increases the expression of osteoprotegerin (OPG, a promoter of invasion and metastasis of breast cancer) and induces its secretion by activating the p38 mitogen-activated protein kinase (MAPK) signaling pathway [35]. Here, IL1B is linked to breast cancer.